Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAM: Early Tenecteplase vs Primary PCI in STEMI
NCT00623623Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2008
- Primary completion
- Sep 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 16
01
Overview
A Phase 3 trial of tenecteplase in ST elevation myocardial infarction (STEMI), sponsored by Boehringer Ingelheim. Started Mar 2008; status: completed.
02
Drugs
tenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00623623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623623.